Digital Pathology & Imaging - software & AI news

Daily news on software, AI, and companies shaping digital pathology & imaging.

Showing 302 results
A diagnostic scan on a clinical desk with an imaging display in the background.

Jun 19, 2026

NHS to transform scan access for 6.6 million people in major tech initiative

The NHS is embarking on a groundbreaking initiative aimed at revolutionizing diagnostic imaging access for 6.6 million people in the West Midlands.The Converged Digital Imaging Platform will establish a unified diagnostic imaging record for every patient in the region. This initiative is poised to enhance the quality of diagnoses by ensuring that patients, regardless of their location, have access to expert interpretations of their scans. By facilitating earlier diagnosis and treatment for condi
A pathology slide on a lab bench in a dimly lit laboratory

Jun 19, 2026

From single-tumour to pan-cancer AI diagnostics

The advancement of AI in cancer diagnostics is shifting from single-tumor analyses to more comprehensive, pan-cancer approaches. This evolution is driven by the integration of advanced algorithms and large language models into clinical workflows.Dr. Tolkach highlighted how diagnostic algorithms in pathology and oncology have progressed significantly, moving from basic diagnostic functions to sophisticated prognostic and predictive models. This shift is now being further enhanced by the use of mu
A minimalist illustration of a butterfly shape symbolizing ultrasound technology.

Jun 18, 2026

Semiconductor AI Medical Tech Stock Butterfly Network (NYSE: BFLY) Soars on Update on Full Body Ultrasound Scanner

Butterfly Network (NYSE: BFLY) has experienced a significant stock surge of 33%, reaching a new 52-week high, following the announcement of a cutting-edge full-body ultrasound scanner by Midjourney Medical. This scanner, which incorporates 40 Butterfly Ultrasound-on-Chip(TM) modules, is poised to revolutionize medical imaging.The stock is trading at approximately $7.61 after hitting a morning high of $8.01, driven by high trading volume. This development aligns with broader trends in the medical
A minimalist representation of a pathology slide and biomarker icon in a dark color scheme.

Jun 18, 2026

AI Pathology Startup Expands Deployment of Cancer Diagnostic Platform

Slideflow Labs is enhancing its cloud-based cancer diagnostic platform, Slideflow Pro, to improve pathology analysis and biomarker development.Slideflow Labs, an AI pathology company originating from the University of Chicago, is expanding the use of its Slideflow Pro platform, which analyzes digitized pathology slides. This platform aims to facilitate the creation of AI-driven biomarkers that can address critical questions in cancer care. Notably, research published in *Nature Cancer* highlight
A medical scan on a lightbox in a dimly lit radiology room

Jun 18, 2026

Midjourney Enters Medical Imaging AI Arena

Midjourney, known for its innovative generative art AI, is venturing into the field of medical imaging, marking a significant shift in its application focus.The company aims to enhance diagnostic accuracy and efficiency for healthcare professionals by leveraging AI technology trained on extensive datasets of medical scans. This training enables the identification of anomalies with greater speed and precision, assisting radiologists in their evaluations.Additionally, Midjourney's entry into this
A minimalist illustration of a tumor biopsy sample on a histology slide in a dark color scheme.

Jun 17, 2026

UChicago AI Pathology Startup Slideflow Labs Advances Precision Diagnostics in Cancer | Newswise

Slideflow Labs, an AI pathology startup emerging from the University of Chicago, is pioneering a cloud-based platform aimed at enhancing precision diagnostics in cancer care.The company is spearheaded by Dr. Alexander T. Pearson and co-founders Sid Ramesh and James Dolezal, who have focused on leveraging computer vision to analyze tumor biopsy samples. Their work includes developing deep learning algorithms capable of predicting various molecular alterations from standard histology slides, there
A stethoscope on a medical chart in a dimly lit examination room

Jun 16, 2026

Community Health AI Alliances

The collaboration between WellSpan Health and Philips is paving the way for innovative AI tools in diagnostics and imaging, marking a significant evolution in community health alliances.This seven-year partnership aims to integrate clinical expertise with advanced technologies, emphasizing a more interconnected approach to healthcare delivery. By engaging in joint research and product development, WellSpan Health is positioned to test and refine new healthcare tools, ensuring they meet practical
Flat illustration of a biosensor in a minimalist style

Jun 14, 2026

Why AI Alone Cannot Fix Broken Diagnostic Systems

The integration of artificial intelligence (AI) in healthcare diagnostics is advancing rapidly, yet experts warn that it cannot address underlying issues in measurement reliability and data quality.AI technologies are increasingly being utilized in various diagnostic tools, including biosensors and imaging systems, with regulatory bodies like the FDA actively reviewing their safety and effectiveness. However, the FDA has also recognized the operational risks associated with these AI systems, par
An ultrasound transducer on a patient's abdomen in a dimly lit clinical room.

Jun 14, 2026

United States Ultrasound Device Market Outlook 2026–2034: How AI, Portability, and Point-of-Care Imaging Are Transforming Diagnostics

The ultrasound device market in the United States is poised for significant growth, driven by technological advancements, particularly in AI and portable imaging systems.Ultrasound technology stands out in medical imaging due to its non-invasive nature and safety, utilizing sound waves to create real-time images without radiation exposure. This versatility makes it crucial across various medical fields, including cardiology and obstetrics. The market is projected to expand from $2.73 billion in
A flat illustration of a fundus camera and an eye, symbolizing diabetic retinopathy screening.

Jun 13, 2026

Andhra Pradesh Launches AI Pilot for Diabetic Retinopathy Screening in Gov Hospitals

The government of Andhra Pradesh has initiated a pilot program utilizing Artificial Intelligence (AI) for the early detection of diabetic retinopathy in government hospitals.This innovative project, announced by Health Minister Y Satya Kumar Yadav, is being rolled out in hospitals located in Guntur, Kurnool, and Visakhapatnam. The AI system will analyze fundus camera images to determine the severity of diabetic retinopathy, which affects around 20% of individuals with diabetes. This condition ca
Silhouette of TROP2 biomarker and IHC assay

Jun 13, 2026

Leica Biosystems expands collaboration to advance AI-powered diagnostics in cancer

Leica Biosystems is expanding its collaboration with AstraZeneca and Daiichi Sankyo to enhance AI-driven diagnostics in cancer, particularly focusing on non-small cell lung cancer (NSCLC) through the TROP2 Normalized Membrane Ratio (NMR) biomarker.This initiative aims to develop an integrated system that includes an immunohistochemistry (IHC) assay and an image analysis algorithm, specifically for research purposes. The collaboration builds on a previous partnership that began in May 2025, lever
A flat illustration of a tobacco leaf representing oral cancer detection.

Jun 12, 2026

AI-based 'MIDAS' Project to Prove a Milestone in Digital Health: UHSR VC Dr. H.K. Agrawal

Dr. H.K. Agrawal, Vice-Chancellor of Pt. Bhagwat Dayal Sharma University of Health Sciences, has highlighted the significance of the 'MIDAS' project, a pioneering AI initiative aimed at enhancing digital health by enabling the early detection of oral cancer, particularly in underserved rural areas.Launched by PGIDS in Rohtak, the MIDAS project is particularly timely given the high prevalence of tobacco-related diseases in Haryana. Dr. Agrawal applauded the efforts of Dr. Mala Kamboj and her team